| Line Item | 2024-12-30 | Y/Y |
|---|---|---|
| Revenue | $2.44B | +9.4% |
| Cost of Revenue | $1.97B | +8.0% |
| Gross Profit | $477.4M | +15.5% |
| R&D Expense | $31.8M | +16.8% |
| SG&A Expense | $170.1M | +13.7% |
| Operating Income | $116.0M | +174.2% |
| Pre-tax Income | $83.9M | — |
| Income Tax | $27.6M | +45.4% |
| Net Income | $56.3M |
| Line Item | 2024-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $503.9M | +11.9% |
| Accounts Receivable | $448.6M | +8.5% |
| Inventory | $225.0M | +5.6% |
| Current Assets | $1.61B | +12.4% |
| Total Assets | $3.47B | +4.5% |
| Current Liabilities | $809.1M | +14.9% |
| Long-term Debt | $914.4M | +0.0% |
| Line Item | 2024-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $236.9M | +26.5% |
| Capital Expenditures | $185.7M | +15.9% |
| Investing Cash Flow | -$146.2M | -58.9% |
| Financing Cash Flow | -$36.8M | +22.8% |
| Free Cash Flow | $51.2M | +89.2% |
| +400.8% |
| EPS (Basic) | $0.55 | +405.6% |
| EPS (Diluted) | $0.54 | +400.0% |
| Stockholders' Equity |
| $1.56B |
| +3.5% |